Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
JCR Impact Factor: 0.1
Year: 2012   |   Volume: 1   |   Issue: 1   |   Page: 31-32     View issue

Long term survival in paratesticular rhabdomyosarcoma

Ritesh Kumar, Shreekant Bharti, Divya Khosla, Rakesh Kapoor

Paratesticular rhabdomyosarcoma (RMS) is a rare tumor arising from the mesenchymal tissues of the spermatic cord, epididymis, testis and testicular tunics. It represents only 7% of all patients entered in the Intergroup Rhabdomyosarcoma Study (IRS) and 17% of all malignant intrascrotal tumors in children less than 15 years old. We report a case of a 13-year-old male with left paratesticular RMS who was treated successfully with surgery and systemic chemotherapy. The patient is disease-free after 7 years of treatment completion.

Cite this article
Kumar R, Bharti S, Khosla D, Kapoor R. Long term survival in paratesticular rhabdomyosarcoma. Clin Cancer Investig J. 2012;1(1):31-2.
Kumar, R., Bharti, S., Khosla, D., & Kapoor, R. (2012). Long term survival in paratesticular rhabdomyosarcoma. Clinical Cancer Investigation Journal, 1(1), 31-32.

Sitemap | What's New | Feedback | Copyright and Disclaimer | Privacy Notice
© Clinical Cancer Investigation Journal | Published by Polaris Publication
Online since 01 December, 2011
Editorial and Ethics Policies
Creative Commons  Open Access Journal View mobile site 
ISSN: Print -2278-1668, Online - 2278-0513